Exiqon A/S Offers Unique Bioinformatics Tool for Design and Selection of LNA(TM) Enhanced qPCR Assays for Combined Analysis of Messenger RNA, MicroRNA and Other ncRNA  
6/14/2012 10:02:54 AM

VEDBAEK, Denmark, June 14, 2012 (GLOBE NEWSWIRE) -- Exiqon A/S (NASDAQ OMX: "EXQ"), a leading supplier of high-value gene expression analysis products, today announced the launch of a new unique state-of-the-art online tool for design of LNA(tm) enhanced qPCR assays for quantitation of messenger RNA and ncRNA in combination with associated microRNAs